HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dong-Hu Sui Selected Research

Carcinoma (Carcinomatosis)

1/2014Preclinical activity of lobaplatin as a single agent and in combination with taxanes for ovarian carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dong-Hu Sui Research Topics

Disease

1Carcinoma (Carcinomatosis)
01/2014
1Neoplasms (Cancer)
01/2014
1Ovarian Neoplasms (Ovarian Cancer)
01/2014

Drug/Important Bio-Agent (IBA)

1lissamine rhodamine B (sulforhodamine B)IBA
01/2014
1lobaplatinIBA
01/2014
1Docetaxel (Taxotere)FDA Link
01/2014
1Cisplatin (Platino)FDA LinkGeneric
01/2014
1PlatinumIBA
01/2014
1Carboplatin (JM8)FDA LinkGeneric
01/2014
1Platinum Compounds (Compounds, Platinum)IBA
01/2014
1Taxoids (Taxanes)IBA
01/2014